Differences in Incidence of Acute Viral Hepatitis between Foreigners and Autochthonous Population in Italy.
Italy
acute viral hepatitis
foreign citizens
incidence
Journal
International journal of environmental research and public health
ISSN: 1660-4601
Titre abrégé: Int J Environ Res Public Health
Pays: Switzerland
ID NLM: 101238455
Informations de publication
Date de publication:
27 07 2021
27 07 2021
Historique:
received:
15
06
2021
revised:
21
07
2021
accepted:
23
07
2021
entrez:
7
8
2021
pubmed:
8
8
2021
medline:
14
8
2021
Statut:
epublish
Résumé
In European countries, the prevalence of HBV and HCV in refugees and migrants tends to reflect the prevalence in their countries of origin. The aim of this study is to analyse acute viral hepatitis cases diagnosed in Italy among foreign citizens and to compare incidence rates in foreigners and Italians. We analysed the cases of each viral hepatitis type among foreigners. Standardised incidence rates were compared between natives and foreigners. Between 2004 and 2019, 15,872 cases of acute viral hepatitis were notified by 10 Italian regions, 14.8% among foreign citizens. Until 2012, the percentage increased gradually, while a fluctuating trend set in from 2013 onwards; in 2019, 23.9% of cases were foreigners. Data from the SEIEVA surveillance show higher standardised incidence rates of hepatitis A and B among foreign citizens; no significant difference emerged between Italians and foreigners in terms of their hepatitis C incidence. foreign citizens have an increased incidence of hepatitis A and B. Regarding hepatitis A, vaccination is strongly recommended to foreigners travelling to their countries of origin. Screening tests for hepatitis B and C infection should be offered to newly arrived migrants from high prevalence countries, or having specific risk factors.
Sections du résumé
BACKGROUND
In European countries, the prevalence of HBV and HCV in refugees and migrants tends to reflect the prevalence in their countries of origin. The aim of this study is to analyse acute viral hepatitis cases diagnosed in Italy among foreign citizens and to compare incidence rates in foreigners and Italians.
METHODS
We analysed the cases of each viral hepatitis type among foreigners. Standardised incidence rates were compared between natives and foreigners.
RESULTS
Between 2004 and 2019, 15,872 cases of acute viral hepatitis were notified by 10 Italian regions, 14.8% among foreign citizens. Until 2012, the percentage increased gradually, while a fluctuating trend set in from 2013 onwards; in 2019, 23.9% of cases were foreigners. Data from the SEIEVA surveillance show higher standardised incidence rates of hepatitis A and B among foreign citizens; no significant difference emerged between Italians and foreigners in terms of their hepatitis C incidence.
CONCLUSIONS
foreign citizens have an increased incidence of hepatitis A and B. Regarding hepatitis A, vaccination is strongly recommended to foreigners travelling to their countries of origin. Screening tests for hepatitis B and C infection should be offered to newly arrived migrants from high prevalence countries, or having specific risk factors.
Identifiants
pubmed: 34360239
pii: ijerph18157944
doi: 10.3390/ijerph18157944
pmc: PMC8345609
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Dig Liver Dis. 2017 Dec;49(12):1368-1372
pubmed: 28818677
Epidemiol Prev. 2021 May-Jun;45(3):173-180
pubmed: 34212698
J Infect Public Health. 2019 Mar - Apr;12(2):200-204
pubmed: 30377049
Vaccine. 2013 Apr 3;31(14):1806-11
pubmed: 23395735
Infect Dis Poverty. 2019 Mar 15;8(1):17
pubmed: 30871599
Health Policy. 2021 Mar;125(3):393-405
pubmed: 33461797
Eur J Obstet Gynecol Reprod Biol. 2020 Nov;254:195-199
pubmed: 33017709
World J Clin Cases. 2018 Nov 6;6(13):589-599
pubmed: 30430114
Hum Vaccin Immunother. 2013 Mar;9(3):636-41
pubmed: 23354158
Infect Dis Poverty. 2017 Feb 9;6(1):33
pubmed: 28179020
Public Health. 2018 May;158:176-182
pubmed: 29628202
Epidemiol Prev. 2021 Jan-Apr;45(1-2):46-53
pubmed: 33884842
J Infect Public Health. 2017 Mar - Apr;10(2):177-184
pubmed: 27161593
Scand J Gastroenterol. 2017 Aug;52(8):893-897
pubmed: 28446048
Public Health. 2020 Aug;185:394-399
pubmed: 32758763
Public Health Rev. 2017 Sep 8;38:22
pubmed: 29450094
J Viral Hepat. 2020 Sep;27(9):941-947
pubmed: 32338810
PLoS Med. 2020 Apr 21;17(4):e1003068
pubmed: 32315297
J Travel Med. 2019 Feb 1;26(2):
pubmed: 30726941
Infez Med. 2016 Sep 1;24(3):210-6
pubmed: 27668901
Clin Infect Dis. 2016 Jun 1;62(11):1412-8
pubmed: 27009250
Public Health. 2015 May;129(5):561-8
pubmed: 25795017
Euro Surveill. 2018 Oct;23(41):
pubmed: 30326991
Eur J Intern Med. 2018 Jul;53:79-84
pubmed: 29475770
Int J Infect Dis. 2020 Dec;101:126-130
pubmed: 32947054
BMC Public Health. 2017 Apr 22;17(1):351
pubmed: 28431498
Lancet Infect Dis. 2018 Sep;18(9):e259-e271
pubmed: 29778396
Euro Surveill. 2018 Jul;23(27):
pubmed: 29991381
Euro Surveill. 2015 Jul 23;20(29):21192
pubmed: 26227370
Euro Surveill. 2018 Aug;23(33):
pubmed: 30131095
Euro Surveill. 2018 Feb;23(6):
pubmed: 29439751
East Mediterr Health J. 2019 Jun 04;25(4):246-253
pubmed: 31210345